Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Inosine Pranobex Market 2018, Forecast to 2023

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

Scope of the Report:
This report focuses on the Inosine Pranobex in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
Inosine Pranobex is widely used to treat Immunomodulation, Antiviral and Other. The most proportion of Inosine Pranobex is to treat Antiviral, and the proportion is about 48.6% in 2017.
Europe region is the largest supplier of Inosine Pranobex, with a production market share nearly 57% in 2017. North America is the second largest supplier of Inosine Pranobex, enjoying revenue market share nearly 8.7% in 2017.
The worldwide market for Inosine Pranobex is expected to grow at a CAGR of roughly 1.8% over the next five years, will reach 210 million US$ in 2023, from 180 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi 
Andrómaco
Yung Shin
Sigma -Tau
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tablet
Syrup

Market Segment by Applications, can be divided into
Immunomodulation
Antiviral
Other

There are 15 Chapters to deeply display the global Inosine Pranobex market.
Chapter 1, to describe Inosine Pranobex Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Inosine Pranobex, with sales, revenue, and price of Inosine Pranobex, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Inosine Pranobex, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Inosine Pranobex market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Inosine Pranobex sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions